Strategic Growth & Partnerships Leader

ALLInBio, Inc.; Palo Alto (CA); Hybrid; USD 250,000 - 450,000; Full time

Job summary

ALLInBio, Inc. in Palo Alto seeks a Head of Corporate Development & Business Development to drive growth through strategic partnerships, licensing, and asset acquisitions. The role reports to the CEO and collaborates with scientific leadership, the Board, and investors.

The ideal candidate has a proven BD track record in pharma/biotech, deep drug-discovery insight, and leads due diligence, deal structuring, and end-to-end negotiations. In-person collaboration with the executive team is expected.

Qualifications

• Proven corporate and business development experience in pharma/biotech.
• Ability to evaluate scientific/clinical data and novel mechanisms.
• Experience leading complex negotiations and due diligence.
• Strong financial and commercial judgment for asset valuation.
• Excellent communication, presentation, and negotiation skills.
• Advanced degree preferred (PhD/MD or equivalent).

Responsibilities

• Oversee corporate governance, records, and external advisors.
• Collaborate with CEO on budgeting and deal-related spend.
• Develop and execute BD strategy aligned with growth goals.
• Build relationships with pharma/biotech firms, academia, and researchers.
• Lead due diligence and present business cases to Board and exec team.
• Negotiate licensing, asset acquisitions, and collaborations.
• Own end-to-end deal execution from term sheet to alliance management.

Skills

Negotiation skills

Communication skills

Industry network

Strategic thinking

Education

Advanced scientific or medical degree (PhD, MD, or equivalent) preferred

Tools

AI tools

Job description

ALLInBio, Inc. in Palo Alto seeks a Head of Corporate Development & Business Development to drive growth through strategic partnerships, licensing, and asset acquisitions. The role reports to the CEO and collaborates with scientific leadership, the Board, and investors.

The ideal candidate has a proven BD track record in pharma/biotech, deep drug-discovery insight, and leads due diligence, deal structuring, and end-to-end negotiations. In-person collaboration with the executive team is expected.